https://orcid.org/0000-0002-7443-4798
Citations (102)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Hikmat Abdel-Razeq, Salah Abbasi, Ghadeer Abdeen, Hazem Abdulelah, Jamil Debs, Sarah Al Masri, Majdi H. Aljadayeh & Abdalla Awidi. (2023) Management of breast cancer patients with BRCA gene mutations in Jordan: perspectives and challenges. Hospital Practice 51:4, pages 184-191.
Read now
Read now
Mok Oh, Ali McBride, Sandipan Bhattacharjee, Marion Slack, Joanne Jeter & Ivo Abraham. (2023) The economic value of knowing BRCA status: universal BRCA testing for breast cancer prevention. Expert Review of Pharmacoeconomics & Outcomes Research 23:3, pages 309-316.
Read now
Read now
Yu Luo, Heming Wu, Qingyan Huang, Hui Rao, Zhikang Yu & Zhixiong Zhong. (2022) The Features of BRCA1 and BRCA2 Germline Mutations in Hakka Ovarian Cancer Patients: BRCA1 C.536 A>T Maybe a Founder Mutation in This Population. International Journal of General Medicine 15, pages 2773-2786.
Read now
Read now
Sung Woo Kim, Tae Hee Kim, Ji Yeon Han, Seul Ki Kim, Jung Ryeol Lee, ung Chul Jee, Chang Suk Suh & Seok Hyun Kim. (2022) Impact of BRCA mutations and hormone receptor status on reproductive potential in breast cancer patients undergoing fertility preservation. Gynecological Endocrinology 38:3, pages 227-230.
Read now
Read now
Bertha Alejandra Martinez-Cannon, Regina Barragan-Carrillo & Cynthia Villarreal-Garza. (2021) Young Women with Breast Cancer in Resource-Limited Settings: What We Know and What We Need to Do Better. Breast Cancer: Targets and Therapy 13, pages 641-650.
Read now
Read now
Maria V. Deligiorgi, Mihalis I. Panayiotidis & Dimitrios T. Trafalis. (2020) Repurposing denosumab in breast cancer beyond prevention of skeletal related events: Could nonclinical data be translated into clinical practice?. Expert Review of Clinical Pharmacology 13:11, pages 1235-1252.
Read now
Read now
Razieh Keikhaee, Zohreh Sanaat, Saeid Mousavi & Abdolreza Shaghaghi. Cross-Cultural Adaptation and Psychometric Validation of the Interview Satisfaction Questionnaire (ISQ) to Assess Unmet Health Communication Needs of Iranian Breast Cancer Patients. Health Communication 0:0, pages 1-11.
Read now
Read now
Articles from other publishers (95)
Andi Wan, Guozhi Zhang, Dandan Ma, Yi Zhang & Xiaowei Qi. (2023) An overview of the research progress of BRCA gene mutations in breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:4, pages 188907.
Crossref
Crossref
Yangyang Liu, Rui Xue, Xixi Duan, Xiaoping Shang, Ming Wang, Fazhan Wang, Linyu Zhu, Lijing Zhang, Xin Ge, Xianlan Zhao, Hongjun Guo, Zhihong Wang, Lindong Zhang, Xiang Gao, Airong Shen, Yuqiao Sheng & Zhihai Qin. (2023) PARP inhibition synergizes with CD47 blockade to promote phagocytosis by tumor-associated macrophages in homologous recombination-proficient tumors. Life Sciences, pages 121790.
Crossref
Crossref
Rafael Vázquez-Romo, Oliver Millan-Catalan, Erika Ruíz-García, Antonio D. Martínez-Gutiérrez, Alberto Alvarado-Miranda, Alma D. Campos-Parra, César López-Camarillo, Nadia Jacobo-Herrera, Eduardo López-Urrutia, Mariano Guardado-Estrada, David Cantú de León & Carlos Pérez-Plasencia. (2023) Pathogenic variant profile in DNA damage response genes correlates with metastatic breast cancer progression-free survival in a Mexican-mestizo population. Frontiers in Oncology 13.
Crossref
Crossref
Elżbieta Senkus, Suzette Delaloge, Susan M. Domchek, Pierfranco Conte, Seock‐Ah Im, Binghe Xu, Anne Armstrong, Norikazu Masuda, Anitra Fielding, Mark Robson & Nadine Tung. (2023)
Olaparib efficacy in patients with germline
BRCA
‐mutated,
HER2
‐negative metastatic breast cancer: Subgroup analyses from the phase
III OlympiAD
trial
. International Journal of Cancer.
Crossref
Crossref
L. Cortesi, M. Venturelli, G. Cortesi, F. Caggia, A. Toss, E. Barbieri, U. De Giorgi, V. Guarneri, A. Musolino, E. De Matteis, A. Zambelli, G. Bisagni & M. Dominici. (2023) A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA). ESMO Open 8:2, pages 101207.
Crossref
Crossref
Emily Brugioni, Elizabeth Cathcart-Rake, Janie Metsker, Elizabeth Gustafson, Lindsey Douglass & Timothy J. Pluard. (2023) Germline BRCA-mutated HER2-negative Advanced Breast Cancer: Overcoming Challenges in Genetic Testing and Clinical Considerations when Using Talazoparib. Clinical Breast Cancer.
Crossref
Crossref
Haixia Liu, Xiaohui Chen, Yimin Jia, Hengyi Chen, Xiaohui Wang, Guoxiang Liu & Yang Luo. (2023) Facing inevitable PARPis resistance: Mechanisms and therapeutic strategies for breast cancer treatment. Interdisciplinary Medicine 1:2.
Crossref
Crossref
Carolina Velazquez, Esin Orhan, Imene Tabet, Lise Fenou, Béatrice Orsetti, José Adélaïde, Arnaud Guille, Simon Thézénas, Evelyne Crapez, Pierre-Emmanuel Colombo, Max Chaffanet, Daniel Birnbaum, Claude Sardet, William Jacot & Charles Theillet. (2023) BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib. Frontiers in Oncology 13.
Crossref
Crossref
Jaeyoung Moon, Ichiwa Kitty, Kusuma Renata, Sisi Qin, Fei Zhao & Wootae Kim. (2023) DNA Damage and Its Role in Cancer Therapeutics. International Journal of Molecular Sciences 24:5, pages 4741.
Crossref
Crossref
Aliaksandr Skrahin, Huma Arshad Cheema, Maqbool Hussain, Nuzhat Noureen Rana, Khalil Ur Rehman, Raman Kumar, Gabriela Oprea, Najim Ameziane, Arndt Rolfs & Volha Skrahina. (2023) Secondary findings in a large Pakistani cohort tested with whole genome sequencing. Life Science Alliance 6:3, pages e202201673.
Crossref
Crossref
Pui San Tan, Cesar Garriga, Ashley Clift, Weiqi Liao, Martina Patone, Carol Coupland, Rachael Bashford-Rogers, Shivan Sivakumar & Julia Hippisley-Cox. (2023) Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case–control study. Gut 72:3, pages 512-521.
Crossref
Crossref
Sanam Shah, Yahya Mahamat-Saleh, Wassila Ait-Hadad, Nicholas A. Koemel, Raphaëlle Varraso, Marie-Christine Boutron-Ruault & Nasser Laouali. (2023) Long-term adherence to healthful and unhealthful plant-based diets and breast cancer risk overall and by hormone receptor and histologic subtypes among postmenopausal females. The American Journal of Clinical Nutrition 117:3, pages 467-476.
Crossref
Crossref
Audrey Mailliez, Veronique D'Hondt, Amelie Lusque, Olivier Caron, Luc Cabel, Anthony Goncalves, Marc Debled, Laurence Gladieff, Jean‐Marc Ferrero, Thierry Petit, Marie Ange Mouret‐Reynier, Jean‐Christophe Eymard, Christelle Levy, Lionel Uwer, Marianne Leheurteur, Isabelle Desmoulins, Thomas Bachelot, Jean‐Sebastien Frenel, Thibault de la Motte Rouge, Gaëtane Simon, William Jacot & Suzette Delaloge. (2022)
Survival outcomes of metastatic breast cancer patients by germline
BRCA1/2
status in a large multicenter real‐world database
. International Journal of Cancer 152:5, pages 921-931.
Crossref
Crossref
Huai-liang Wu, Zi-yin Luo, Zong-lin He, Yue Gong, Miao Mo, Wai-kit Ming & Guang-yu Liu. (2022) All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits. British Journal of Cancer 128:4, pages 638-646.
Crossref
Crossref
Serena Bertozzi, Ambrogio P. Londero, Anjeza Xholli, Guglielmo Azioni, Roberta Di Vora, Michele Paudice, Ines Bucimazza, Carla Cedolini & Angelo Cagnacci. (2023) Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review. Journal of Clinical Medicine 12:4, pages 1422.
Crossref
Crossref
Carlos Arturo Gonzalez Nuñez, Paula Anel Cabrera Galeana, Sandy Ruiz Cruz & Alexandra Garcilazo Reyes. 2023. BRCA1 and BRCA2 Mutations - Diagnostic and Therapeutic Implications. BRCA1 and BRCA2 Mutations - Diagnostic and Therapeutic Implications.
Thomas J. Herzog, Ignace Vergote, Leonard G. Gomella, Tsveta Milenkova, Tim French, Raffi Tonikian, Christian Poehlein & Maha Hussain. (2023) Testing for homologous recombination repair or homologous recombination deficiency for poly (ADP-ribose) polymerase inhibitors: A current perspective. European Journal of Cancer 179, pages 136-146.
Crossref
Crossref
Songporn Oranratnachai, Watchalawalee Yamkaew, Atchara Tunteeratum, Thongchai Sukarayothin, Nareenart Iemwimangsa & Ravat Panvichien. (2022)
Characteristics of breast cancer patients tested for germline
BRCA1/2
mutations by next‐generation sequencing in Ramathibodi Hospital, Mahidol University
. Cancer Reports 6:1.
Crossref
Crossref
Auhood Nassar, Abdel-Rahman N. Zekri, Mahmoud M. Kamel, Mostafa H. Elberry, Mai M. Lotfy, Mohamed G. Seadawy, Zeinab K. Hassan, Hany K. Soliman, Ahmed M. Lymona & Amira Salah El-Din Youssef. (2022) Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study. Genes 14:1, pages 106.
Crossref
Crossref
Yunuo Zhang, Heming Wu, Zhikang Yu, Liang Li, Jinhong Zhang, Xinhong Liang & Qingyan Huang. (2022) Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients. BMC Cancer 22:1.
Crossref
Crossref
Maria Valeria Esposito, Bruno Fosso, Marcella Nunziato, Giorgio Casaburi, Valeria D’Argenio, Alessandra Calabrese, Massimiliano D’Aiuto, Gerardo Botti, Graziano Pesole & Francesco Salvatore. (2022) Microbiome composition indicate dysbiosis and lower richness in tumor breast tissues compared to healthy adjacent paired tissue, within the same women. BMC Cancer 22:1.
Crossref
Crossref
Mónica Cejuela, Andrea Vethencourt & Sonia Pernas. (2022) Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer. Current Oncology Reports 24:12, pages 1801-1819.
Crossref
Crossref
Ronit Pinchas-Mizrachi, Judith Jacobson Liptz, Beth G. Zalcman & Anat Romem. (2022) Disparities in Breast Cancer Mortality Rates in Israel among Urban and Rural Women. International Journal of Environmental Research and Public Health 19:23, pages 15785.
Crossref
Crossref
William Jacot, Amélie Lusque, Cécile Vicier, Audrey Mailliez, Thibault de La Motte Rouge, Luc Cabel, Christelle Levy, Anne Patsouris, Isabelle Desmoulins, Lionel Uwer, Jean-Christophe Thery, Mathieu Robain, Olivier Caron, Olivier Tredan, Thomas Filleron, Jean-Sébastien Frenel & Suzette Delaloge. (2022) Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations. British Journal of Cancer 127:11, pages 1963-1973.
Crossref
Crossref
Thorsten Mosler, H Irem Baymaz, Justus F Gräf, Ivan Mikicic, Georges Blattner, Edward Bartlett, Matthias Ostermaier, Rossana Piccinno, Jiwen Yang, Andrea Voigt, Marco Gatti, Stefania Pellegrino, Matthias Altmeyer, Katja Luck, Ivan Ahel, Vassilis Roukos & Petra Beli. (2022) PARP1 proximity proteomics reveals interaction partners at stressed replication forks. Nucleic Acids Research 50:20, pages 11600-11618.
Crossref
Crossref
Tira J. Tan, J. Lynn Fink, Timothy K. Tay, Binny Jaradi, Nathan Stone, Paul Waring, Kevin M. Koo, Puay Hoon Tan, Daniel S. Tan & Rebecca A. Dent. (2022)
Exquisitely Platinum-Sensitive Triple-Negative Breast Cancer, Time for
BRCA
Methylation Testing?
. JCO Precision Oncology:6.
Crossref
Crossref
Benedikt Zang, Malina Helms, Laura Besch, Nanette Kalmbach, Stephanie Stegen, Jens-Uwe Blohmer & Dorothee Speiser. (2022) Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center. Archives of Gynecology and Obstetrics 307:5, pages 1585-1592.
Crossref
Crossref
Mahesh Sarki, Chang Ming, Monica Aceti, Günther Fink, Souria Aissaoui, Nicole Bürki, Rossella Graffeo, Karl Heinimann, Maria Caiata Zufferey, Christian Monnerat, Manuela Rabaglio, Ursina Zürrer-Härdi, Pierre O. Chappuis & Maria C. Katapodi. (2022) Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort. Journal of Personalized Medicine 12:10, pages 1740.
Crossref
Crossref
Anastasiia Samusieva, Svitlana Serga, Sergiy Klymenko, Lyudmila Rybchenko, Bohdana Klimuk, Liubov Zakhartseva, Natalia Gorovenko, Olga Lobanova, Zoia Rossokha, Liliia Fishchuk, Nataliia Levkovich, Nataliia Medvedieva, Olena Popova, Valeriy Cheshuk, Mariia Inomistova, Natalia Khranovska, Oksana Skachkova, Yurii Michailovich, Olga Ponomarova & Iryna Kozeretska. (2022) Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine. Breast Cancer Research and Treatment 195:3, pages 453-459.
Crossref
Crossref
Yong‐Quan Lee, Sook‐Yee Yoon, Tiara Hassan, Heamanthaa Padmanabhan, Cheng‐Har Yip, Wee‐Teik Keng, Meow‐Keong Thong, Muhammad Azrif Ahmad Annuar, Nur Aishah Mohd Taib & Soo‐Hwang Teo. (2022) Attitudes and training needs of oncologists and surgeons in mainstreaming breast cancer genetic counseling in a low‐to‐middle income Asian country. Journal of Genetic Counseling 31:5, pages 1080-1089.
Crossref
Crossref
Wesley L Cai, Jocelyn Fang-Yi Chen, Huacui Chen, Emily Wingrove, Sarah J Kurley, Lok Hei Chan, Meiling Zhang, Anna Arnal-Estape, Minghui Zhao, Amer Balabaki, Wenxue Li, Xufen Yu, Ethan D Krop, Yali Dou, Yansheng Liu, Jian Jin, Thomas F Westbrook, Don X Nguyen & Qin Yan. (2022) Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation. eLife 11.
Crossref
Crossref
Marzieh Nikoo, Mohammad Rudiansyah, Dmitry Olegovich Bokov, Nurlan T. Jainakbaev, Wanich Suksatan, Mohammad Javed Ansari, Lakshmi Thangavelu, Supat Chupradit, Amir Zamani, Ali Adili, Navid Shomali & Morteza Akbari. (2022)
Potential of chimeric antigen receptor (
CAR
)‐redirected immune cells in breast cancer therapies: Recent advances
. Journal of Cellular and Molecular Medicine 26:15, pages 4137-4156.
Crossref
Crossref
Lauren C. Tindale, Almira Zhantuyakova, Stephanie Lam, Michelle Woo, Janice S. Kwon, Gillian E. Hanley, Bartha Knoppers, Kasmintan A. Schrader, Stuart J. Peacock, Aline Talhouk, Trevor Dummer, Kelly Metcalfe, Nora Pashayan, William D. Foulkes, Ranjit Manchanda, David Huntsman, Gavin Stuart, Jacques Simard & Lesa Dawson. (2022) Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention. Current Oncology 29:7, pages 4632-4646.
Crossref
Crossref
Claudia Piombino & Laura Cortesi. (2022) Insights into the Possible Molecular Mechanisms of Resistance to PARP Inhibitors. Cancers 14:11, pages 2804.
Crossref
Crossref
Chi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, Pei-Ju Lien, Yen-Shu Lin, Ta-Chung Chao, Chin-Jung Feng, Yen-Jen Chen, Jiun-I Lai, Nam Nhut Phan, Chih-Yi Hsu, Jen-Hwey Chiu & Ling-Ming Tseng. (2022) Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers. Annals of Surgical Oncology 29:6, pages 3578-3590.
Crossref
Crossref
Jason A. Mouabbi, Amy Hassan, Bora Lim, Gabriel N. Hortobagyi, Debasish Tripathy & Rachel M. Layman. (2022) Invasive lobular carcinoma: an understudied emergent subtype of breast cancer. Breast Cancer Research and Treatment 193:2, pages 253-264.
Crossref
Crossref
Robert S. Miller, Stella Mokiou, Aliki Taylor, Ping Sun & Katherine Baria. (2022) Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a CancerLinQ® study. Breast Cancer Research and Treatment 193:1, pages 83-94.
Crossref
Crossref
Giovanni Paolino, Riccardo Pampena, Matteo Riccardo Di Nicola, Caterina Longo, Alessia Rognone, Stefania Zambelli, Giampaolo Bianchini & Santo Raffaele Mercuri. (2022) Dermatological and Dermoscopic Baselines in BRCA Mutation Carriers. Frontiers in Medicine 9.
Crossref
Crossref
Surendra Kumar Shukla, B. Muthu Kumar, Divyanshu Sinha, Varsha Nemade, Shynar Mussiraliyeva, R. Sugumar & Rituraj Jain. (2022) Apprehending the Effect of Internet of Things (IoT) Enables Big Data Processing through Multinetwork in Supporting High-Quality Food Products to Reduce Breast Cancer. Journal of Food Quality 2022, pages 1-12.
Crossref
Crossref
Maria Russi, Domenico Marson, Alice Fermeglia, Suzana Aulic, Maurizio Fermeglia, Erik Laurini & Sabrina Pricl. (2022) The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer. Pharmacology & Therapeutics 232, pages 108009.
Crossref
Crossref
Michael P Lux, Katie Lewis, Alex Rider & Alexander Niyazov. (2022)
Real-world multi-country study of
BRCA1/2
mutation testing among adult women with HER2-negative advanced breast cancer
. Future Oncology 18:9, pages 1089-1101.
Crossref
Crossref
Abhenil Mittal, S. V. S. Deo, Ajay Gogia, Atul Batra, Akash Kumar, Sandeep Bhoriwal, Koushik Sinha Deb, Ekta Dhamija, Sanjay Thulkar, V. L. Ramprasad, Olufunmilayo Olopade & Raja Pramanik. (2021) Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center. Annals of Surgical Oncology 29:2, pages 1423-1432.
Crossref
Crossref
Ana Krivokuca, Milica Mihajlovic, Snezana Susnjar, Ivana Bozovic Spasojevic, Ivana Minic, Lazar Popovic & Mirjana Brankovic-Magic. (2022) Mutational profile of hereditary breast and ovarian cancer – Establishing genetic testing guidelines in a developing country. Current Problems in Cancer 46:1, pages 100767.
Crossref
Crossref
Dafina Petrova, Maite Cruz & María-José Sánchez. (2022) BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implications. The Breast 61, pages 66-76.
Crossref
Crossref
Adviti Naik & Julie Decock. (2021) Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy. Molecular Oncology 16:4, pages 885-903.
Crossref
Crossref
Gabriel Duque Pannain, Marcelo Antonini, Odair Ferraro, Juliana Monte Real & Reginaldo Guedes Coelho Lopes. (2022) Comparative analysis between screening mammography performed in patients at usual
risk and at high risk for breast cancer. Mastology 32.
Crossref
Crossref
Michael P. Lux, Thomas Decker, Eva Diana Runkel, Alexander Niyazov, Ruben G.W. Quek, Norbert Marschner & Nadia Harbeck. (2022) Awareness and Availability of Routine Germline <b><i>BRCA1/2</i></b> Mutation Testing in Patients with Advanced Breast Cancer in Germany. Breast Care 17:1, pages 40-46.
Crossref
Crossref
M. A. Frolova & M. B. Stenina. (2021) Peculiarities of BRCA1/2 testing in patients with advanced HER2-negative breast cancer in the Russian Federation (results of a survey of Russian oncologists). Malignant tumours 11:2, pages 38-44.
Crossref
Crossref
Sudeep Gupta, Senthil Rajappa, Suresh Advani, Amit Agarwal, Shyam Aggarwal, Chanchal Goswami, Satya Dattatreya Palanki, Devavrat Arya, Shekhar Patil & Rohit Kodagali. (2021)
Prevalence of
BRCA1
and
BRCA2
Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study
. JCO Global Oncology:7, pages 849-861.
Crossref
Crossref
Lucie G. Hallenstein, Carol Sorensen, Lorraine Hodgson, Shelly Wen, Justin Westhuyzen, Carmen Hansen, Andrew T. J. Last, Julan V. Amalaseelan, Shehnarz Salindera, William Ross, Allan D. Spigelman, Thomas P. Shakespeare & Noel J. Aherne. (2021) Assessment of genetic referrals and outcomes for women with triple negative breast cancer in regional cancer centres in Australia. Hereditary Cancer in Clinical Practice 19:1.
Crossref
Crossref
Ziqi Jia, Jiaxin Li, Yuelun Zhang, Xin Wang, Jiahua Xing, Zeyu Xing, Xin Huang, Gang Liu, Menglu Zhang, Kexin Feng, Jiang Wu, Wenyan Wang, Jie Wang, Jiaqi Liu & Xiang Wang. (2021) Contralateral risk-reducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysis. Cancer Cell International 21:1.
Crossref
Crossref
Lauren J Beesley, Irina Bondarenko, Michael R Elliot, Allison W Kurian, Steven J Katz & Jeremy MG Taylor. (2021) Multiple imputation with missing data indicators. Statistical Methods in Medical Research 30:12, pages 2685-2700.
Crossref
Crossref
Jyoti Bajpai, Pradeep Ventrapati, Shalaka Joshi, Tabassum Wadasadawala, Sushmita Rath, Rima Pathak, Ravindra Nandhana, Samarpita Mohanty, Qurratulain Chougle, Mitchelle Engineer, Nissie Abraham, Jaya Ghosh, Nita Nair, Seema Gulia, Palak Popat, Patil A, Tanuja Sheth, Sangeeta Desai, Meenakshi Thakur, Venkatesh Rangrajan, Vani Parmar, R. Sarin, S. Gupta & R.A. Badwe. (2021) Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India. The Breast 60, pages 177-184.
Crossref
Crossref
Tünde Kovács, Edit Mikó, Gyula Ujlaki, Heba Yousef, Viktória Csontos, Karen Uray & Peter Bai. (2021) The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer. Cancer and Metastasis Reviews 40:4, pages 1223-1249.
Crossref
Crossref
Nanna Jørgensen, Thomas Vauvert F. Hviid, Lise B. Nielsen, Ida M. H. Sønderstrup, Jens Ole Eriksen, Bent Ejlertsen, Anne-Marie Gerdes, Torben A. Kruse, Mads Thomassen, Maj-Britt Jensen & Anne-Vibeke Lænkholm. (2021) Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer. British Journal of Cancer 125:10, pages 1388-1398.
Crossref
Crossref
Takashi Hirayama, Yoshihide Inayama, Suguru Odajima, Akina Yamanaka, Masayuki Sekine, Yasuhisa Terao, Keiko Koide, Yoshimitsu Kuwabara, Hideaki Yahata, Nozomu Yanaihara, Satoru Nagase, Yoichi Kobayashi & Akihiko Sekizawa. (2021) A report on the 73th Annual Congress of the Japan Society of Obstetrics and Gynecology International Workshop for Junior Fellows: Risk‐reducing surgery for hereditary breast and ovarian cancer. Journal of Obstetrics and Gynaecology Research 47:11, pages 3761-3766.
Crossref
Crossref
M.K. Ibragimova, E.V. Kokorina, M.M. Tsyganov, O.N. Churuksaeva & N.V. Litviakov. (2021) Human papillomavirus and ovarian cancer (review of literature and meta-analysis). Infection, Genetics and Evolution 95, pages 105086.
Crossref
Crossref
Annarita Fanizzi, Maurizio Cosmo Ressa, Gianluca Gatta, Cristian Cristofaro, Valerio De Santis, Vittorio Didonna, Sergio Diotaiuti, Daniele La Forgia, Nicole Petruzzellis, Pasquale Tamborra, Vito Lorusso & Raffaella Massafra. (2021) Disease-Free Survival after Breast Conservation Therapy vs. Mastectomy of Patients with T1/2 Breast Cancer and No Lymph Node Metastases: Our Experience. Applied Sciences 11:21, pages 9800.
Crossref
Crossref
Reshma Mahtani, Muaiad Kittaneh, Kevin Kalinsky, Eleftherios Mamounas, Sunil Badve, Charles Vogel, Elyse Lower, Lee Schwartzberg & Mark Pegram. (2021) Advances in Therapeutic Approaches for Triple-Negative Breast Cancer. Clinical Breast Cancer 21:5, pages 383-390.
Crossref
Crossref
Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos, Marcel Silva Luz, João Victor Silva Souza, Samuel Luca Rocha Pinheiro, Wedja Rafaela de Souza, Matheus Sande Loureiro & Fabrício Freire de Melo. (2021) Oncolytic virus therapy in cancer: A current review. World Journal of Virology 10:5, pages 229-255.
Crossref
Crossref
Noriko Senda, Nobuko Kawaguchi‐Sakita, Masahiro Kawashima, Yukiko Inagaki‐Kawata, Kenichi Yoshida, Masahiro Takada, Masako Kataoka, Masae Torii, Tomomi Nishimura, Kosuke Kawaguchi, Eiji Suzuki, Yuki Kataoka, Yoshiaki Matsumoto, Hiroshi Yoshibayashi, Kazuhiko Yamagami, Shigeru Tsuyuki, Sachiko Takahara, Akira Yamauchi, Nobuhiko Shinkura, Hironori Kato, Yoshio Moriguchi, Ryuji Okamura, Norimichi Kan, Hirofumi Suwa, Shingo Sakata, Susumu Mashima, Fumiaki Yotsumoto, Tsuyoshi Tachibana, Mitsuru Tanaka, Kaori Togashi, Hironori Haga, Takahiro Yamada, Shinji Kosugi, Takashi Inamoto, Masahiro Sugimoto, Seishi Ogawa & Masakazu Toi. (2021) Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population. Cancer Science 112:8, pages 3338-3348.
Crossref
Crossref
Fernando Augusto Batista Campos, Etienne Rouleau, Giovana Tardin Torrezan, Dirce Maria Carraro, José Claudio Casali da Rocha, Higor Kassouf Mantovani, Leonardo Roberto da Silva, Cynthia Aparecida Bueno de Toledo Osório, Solange Moraes Sanches, Sandrine M. Caputo & Elizabeth Santana dos Santos. (2021) Genetic Landscape of Male Breast Cancer. Cancers 13:14, pages 3535.
Crossref
Crossref
Karen A. Gelmon, Peter A. Fasching, Fergus J. Couch, Judith Balmaña, Suzette Delaloge, Intidhar Labidi-Galy, James Bennett, Susan McCutcheon, Graham Walker, Joyce O'Shaughnessy, Constanta Timcheva, Antoaneta Tomova, Andrea Eisen, Karen Gelmon, Julie Lemieux, Fernando Bazan, Hugues Bourgeois, Camille Chakiba, Mohamad Chehimi, Florence Dalenc, Thibault De La Motte Rouge, Jean-Sébastien Frenel, Anthony Gonçalves, Anne Claire Hardy-Bessard, Regine Lamy, Christelle Levy, Alain Lortholary, Audrey Mailliez, Jacques Medioni, Anne Patsouris, Dominique Spaeth, Luis Teixeira, Isabelle Tennevet, Cristian Villanueva, Benoit You, Johannes Ettl, Bernd Gerber, Oliver Hoffmann, Tjoung-Won Park-Simon, Mattea Reinisch, Joke Tio, Pauline Wimberger, Katalin Boer, Alberto Ballestrero, Giampaolo Bianchini, Laura Biganzoli, Roberto Bordonaro, Francesco Cognetti, Michelino De Laurentiis, Sabino De Placido, Valentina Guarneri, Filippo Montemurro, Giuseppe Naso, Armando Santoro, Claudio Zamagni, Seung-Jin Kim, Seigo Nakamura, Yee Soo Chae, Eun Kyung Cho, Kim Jee Hyun, Seock-Ah Im, Keun Seok Lee, Yeon Hee Park, Joo Hyuk Sohn, Tomasz Byrski, Tomasz Huzarski, Bozena Kukielka-Budny, Zbigniew Nowecki, Renata Szoszkiewicz, Rafal Tarnawski, Viktoria Dvornichenko, Fedor Moiseenko, Guzel Mukhametshina, Elena Poddubskaya, Ekaterina Popova, Anna Tarasova, Anna Vats, Bárbara Adamo, Raquel Andrés Conejero, Antonio Antón Torres, Judith Balmaña Gelpi, Nieves Díaz Fernández, Alejandro Falcón González, Juan Garcia, Isabel Lorenzo-Lorenzo, Fernando Moreno Antón, Marta Santisteban, Agostina Stradella, Chiun-Sheng Huang, Sercan Aksoy, Cagatay Arslan, Mehmet Artac, Adnan Aydiner, Ozgur Ozyilkan, Emel Sezer, Anne Armstrong, Sophie Barrett, Annabel Borley, Zoe Kemp, Caroline Michie, Mukesh Mukesh, Timothy Perren, Angela Swampillai & Tammy Young. (2021) Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis. European Journal of Cancer 152, pages 68-77.
Crossref
Crossref
Armando Aranda-Anzaldo & Myrna A. R. Dent. (2021) Is cancer a disease set up by cellular stress responses?. Cell Stress and Chaperones 26:4, pages 597-609.
Crossref
Crossref
Pongtawat Lertwilaiwittaya, Ekkapong Roothumnong, Panee Nakthong, Peerawat Dungort, Chutima Meesamarnpong, Warisara Tansa-Nga, Khontawan Pongsuktavorn, Supakit Wiboonthanasarn, Warunya Tititumjariya, Wanna Thongnoppakhun, Sirisak Chanprasert, Chanin Limwongse & Manop Pithukpakorn. (2021) Thai patients who fulfilled NCCN criteria for breast/ovarian cancer genetic assessment demonstrated high prevalence of germline mutations in cancer susceptibility genes: implication to Asian population testing. Breast Cancer Research and Treatment 188:1, pages 237-248.
Crossref
Crossref
Hans H. Kreipe & P. Sinn. (2021) Prädiktive Mutationsdiagnostik bei MammakarzinomenRelevant mutations in predictive breast cancer pathology. Der Pathologe 42:4, pages 399-404.
Crossref
Crossref
Na Li, Belle W. X. Lim, Ella R. Thompson, Simone McInerny, Magnus Zethoven, Dane Cheasley, Simone M. Rowley, Michelle W. Wong-Brown, Lisa Devereux, Kylie L. Gorringe, Erica K. Sloan, Alison Trainer, Rodney J. Scott, Paul A. James & Ian G. Campbell. (2021) Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study. npj Breast Cancer 7:1.
Crossref
Crossref
Verônica Mollica Govoni, Tereza Cristina Da Silva, Juliana Mariotti Guerra, Isabel Veloso Alves Pereira, Felisbina Luisa Queiroga & Bruno Cogliati. (2021)
Genetic variants of
BRCA1
and
BRCA2
genes in cats with mammary gland carcinoma
. Veterinary and Comparative Oncology 19:2, pages 404-408.
Crossref
Crossref
Ibrahim Sahin & Hanife Saat. (2021) A novel BRCA1 duplication and new insights on the spectrum and frequency of germline large genomic rearrangements in BRCA1/BRCA2. Molecular Biology Reports 48:6, pages 5057-5062.
Crossref
Crossref
Hesham Elghazaly, Hope S. Rugo, Hamdy A. Azim, Sandra M. Swain, Banu Arun, Matti Aapro, Edith A. Perez, Benjamin O. Anderson, Frederique Penault-Llorca, Pierfranco Conte, Nagi S. El Saghir, Cheng-Har Yip, Marwan Ghosn, Philip Poortmans, Mohamed A. Shehata, Armando E. Giuliano, Jessica W. T. Leung, Valentina Guarneri, Joseph Gligorov, Bahadir M. Gulluoglu, Hany Abdel Aziz, Mona Frolova, Mohamed Sabry, Charles M. Balch, Roberto Orecchia, Heba M. El-Zawahry, Sana Al-Sukhun, Khaled Abdel Karim, Alaa Kandil, Ruslan M. Paltuev, Meteb Foheidi, Mohamed El-Shinawi, Manal ElMahdy, Omalkhair Abulkhair, Wentao Yang, Adel T. Aref, Joaira Bakkach, Nermean Bahie Eldin & Hagar Elghazawy. (2021) Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer. Cancers 13:9, pages 2262.
Crossref
Crossref
Laura Cortesi, Hope S. Rugo & Christian Jackisch. (2021) An Overview of PARP Inhibitors for the Treatment of Breast Cancer. Targeted Oncology 16:3, pages 255-282.
Crossref
Crossref
Ewelina Szczerba, Katarzyna Kamińska, Tomasz Mierzwa, Marcin Misiek, Janusz Kowalewski & Marzena Anna Lewandowska. (2021) BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing. Genes 12:4, pages 519.
Crossref
Crossref
Angelo G. Corradini, Anna Cremonini, Maria G. Cattani, Maria C. Cucchi, Gianni Saguatti, Antonella Baldissera, Antonella Mura, Selena Ciabatti & Maria P. Foschini. (2021) Which type of cancer is detected in breast screening programs? Review of the literature with focus on the most frequent histological features. Pathologica 113:2, pages 85-94.
Crossref
Crossref
K Özdemir, H Gürkan, S Demir, E Atli, Y Özen, A Sezer, N Tunçbilek & İ Çicin. (2021)
Investigation of the relationship of
TNFRSF11A
gene polymorphisms with breast cancer development and metastasis risk in patients with
BRCA1
or
BRCA2
pathogenic variants living in the Trakya region of Turkey
. Balkan Journal of Medical Genetics 23:2, pages 49-58.
Crossref
Crossref
Maiko Okano, Tadashi Nomizu, Kazunoshin Tachibana, Miki Nagatsuka, Masami Matsuzaki, Naoto Katagata, Toru Ohtake, Shiro Yokoyama, Masami Arai & Seigo Nakamura. (2020) The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database. Journal of Human Genetics 66:3, pages 307-314.
Crossref
Crossref
Arsen Arakelyan, Ani Melkonyan, Siras Hakobyan, Uljana Boyarskih, Arman Simonyan, Lilit Nersisyan, Maria Nikoghosyan, Maxim Filipenko & Hans Binder. (2021) Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers. International Journal of Molecular Sciences 22:3, pages 1266.
Crossref
Crossref
Rafael Everton Assunção Ribeiro da Costa, Fergus Tomás Rocha de Oliveira, Ana Lúcia Nascimento Araújo & Sabas Carlos Vieira. (2021) Pathogenic variants inBRCA1/2genes among patientswith triple-negative breast cancer: a case series. Mastology 31.
Crossref
Crossref
. (2021) BRCA1 and BRCA2 genes mutations among women with clinical signs of hereditary breast cancer in western Belarus. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine":42.
Crossref
Crossref
Nabila El-Sheikh, Nahla O Mousa, Amany M Tawfeik, Alaa M Saleh, Iman Elshikh, Mohamed Deyab, Faten Ragheb, Manar M Moneer, Ahmed Kawashti, Ahmed Osman & Mohamed Elrefaei. (2021) Assessment of Human Papillomavirus Infection and Risk Factors in Egyptian Women With Breast Cancer. Breast Cancer: Basic and Clinical Research 15, pages 117822342199627.
Crossref
Crossref
Jacopo Nori, Maninderpal Kaur, Anat Kornecki, J. Devi Meenal & Martin J. YaffeJacopo Nori, Maninderpal Kaur, Anat Kornecki, J. Devi Meenal & Martin J. Yaffe. 2021. Atlas of Contrast-Enhanced Mammography. Atlas of Contrast-Enhanced Mammography
187
242
.
Mann Ang, Martin Borg & Michael E. O’Callaghan. (2020) Survival outcomes in men with a positive family history of prostate cancer: a registry based study. BMC Cancer 20:1.
Crossref
Crossref
Suresh Alagar & Ranjit Prasad Bahadur. (2020) DSS1 allosterically regulates the conformation of the tower domain of BRCA2 that has dsDNA binding specificity for homologous recombination. International Journal of Biological Macromolecules 165, pages 918-929.
Crossref
Crossref
Nora Pashayan, Antonis C. Antoniou, Urska Ivanus, Laura J. Esserman, Douglas F. Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D. Gareth Evans, Jacques Simard, Montserrat Garcia-Closas, Rita Schmutzler, Odette Wegwarth, Paul Pharoah, Sowmiya Moorthie, Sandrine De Montgolfier, Camille Baron, Zdenko Herceg, Clare Turnbull, Corinne Balleyguier, Paolo Giorgi Rossi, Jelle Wesseling, David Ritchie, Marc Tischkowitz, Mireille Broeders, Dan Reisel, Andres Metspalu, Thomas Callender, Harry de Koning, Peter Devilee, Suzette Delaloge, Marjanka K. Schmidt & Martin Widschwendter. (2020) Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nature Reviews Clinical Oncology 17:11, pages 687-705.
Crossref
Crossref
Przemysław Sitarek, Anna Merecz-Sadowska, Tomasz Śliwiński, Radosław Zajdel & Tomasz Kowalczyk. (2020) An In Vitro Evaluation of the Molecular Mechanisms of Action of Medical Plants from the Lamiaceae Family as Effective Sources of Active Compounds against Human Cancer Cell Lines. Cancers 12:10, pages 2957.
Crossref
Crossref
Maddison Rose, Joshua T. Burgess, Kenneth O’Byrne, Derek J. Richard & Emma Bolderson. (2020) PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Silvia J. Serrano-Gomez, Maria Carolina Sanabria-Salas & Laura Fejerman. (2020) Breast Cancer Health Disparities in Hispanics/Latinas. Current Breast Cancer Reports 12:3, pages 175-184.
Crossref
Crossref
Ranjit Manchanda, Sari LiebermanFaiza Gaba, Amnon Lahad & Ephrat Levy-Lahad. (2020) Population Screening for Inherited Predisposition to Breast and Ovarian Cancer. Annual Review of Genomics and Human Genetics 21:1, pages 373-412.
Crossref
Crossref
Tae-Min Kim, In Seok Yang, Byung-Joon Seung, Sejoon Lee, Dohyun Kim, Yoo-Jin Ha, Mi-kyoung Seo, Ka-Kyung Kim, Hyun Seok Kim, Jae-Ho Cheong, Jung-Hyang Sur, Hojung Nam & Sangwoo Kim. (2020) Cross-species oncogenic signatures of breast cancer in canine mammary tumors. Nature Communications 11:1.
Crossref
Crossref
Subash Thapa, Anja Leppin, Rikke Kristensen, Mette Just Bonde & Arja R Aro. (2020) Implementation of interventions targeting the uptake of genetic testing services for breast cancer risk: protocol for a systematic review. BMJ Open 10:6, pages e031727.
Crossref
Crossref
Daniele Giardiello, Michael Hauptmann, Ewout W. Steyerberg, Muriel A. Adank, Delal Akdeniz, Jannet C. Blom, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Mariël Brinkhuis, Jenny Chang-Claude, Kamila Czene, Peter Devilee, Alison M. Dunning, Douglas F. Easton, Diana M. Eccles, Peter A. Fasching, Jonine Figueroa, Henrik Flyger, Montserrat García-Closas, Lothar Haeberle, Christopher A. Haiman, Per Hall, Ute Hamann, John L. Hopper, Agnes Jager, Anna Jakubowska, Audrey Jung, Renske Keeman, Linetta B. Koppert, Iris Kramer, Diether Lambrechts, Loic Le Marchand, Annika Lindblom, Jan Lubiński, Mehdi Manoochehri, Luigi Mariani, Heli Nevanlinna, Hester S. A. Oldenburg, Saskia Pelders, Paul D. P. Pharoah, Mitul Shah, Sabine Siesling, Vincent T. H. B. M. Smit, Melissa C. Southey, William J. Tapper, Rob A. E. M. Tollenaar, Alexandra J. van den Broek, Carolien H. M. van Deurzen, Flora E. van Leeuwen, Chantal van Ongeval, Laura J. Van’t Veer, Qin Wang, Camilla Wendt, Pieter J. Westenend, Maartje J. Hooning & Marjanka K. Schmidt. (2020) Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts. Breast Cancer Research and Treatment 181:2, pages 423-434.
Crossref
Crossref
Antonia Busse & Diana Lüftner. (2020) Checkpointinhibitoren beim metastasierten Mammakarzinom: Momentane Indikation und aktuelle EntwicklungenCheckpoint inhibitors in metastatic breast cancer: current indication and developments. Der Onkologe 26:6, pages 512-517.
Crossref
Crossref
Stephanie Boisson-Dupuis. (2020) The monogenic basis of human tuberculosis. Human Genetics 139:6-7, pages 1001-1009.
Crossref
Crossref
Elise Berthel, Anne Vincent, Lauriane Eberst, Adrian Gabriel Torres, Estelle Dacheux, Catherine Rey, Virginie Marcel, Hermes Paraqindes, Joël Lachuer, Frédéric Catez, Lluis Ribas de Pouplana, Isabelle Treilleux, Jean-Jacques Diaz & Nicole Dalla Venezia. (2020) Uncovering the Translational Regulatory Activity of the Tumor Suppressor BRCA1. Cells 9:4, pages 941.
Crossref
Crossref
Yue Li, Xiaoyan Zhou, Jiali Liu, Yang Yin, Xiaohong Yuan, Ruihua Yang, Qi Wang, Jing Ji & Qian He. (2020)
Differentially expressed genes and key molecules of
BRCA1/2
-mutant breast cancer: evidence from bioinformatics analyses
. PeerJ 8, pages e8403.
Crossref
Crossref
Ying Ma, Nai-peng Zhang, Ning An, Wen-yuan Li, Wei Zhao & Yan-cui Liu. (2019) Clinical efficacy of weekly cisplatin for treatment of patients with breast cancer. Medicine 98:37, pages e17114.
Crossref
Crossref